MedTrace Logo

Efficacy and Safety of AJU-S56 in Dry Eye Syndrome Patients

NCT06337981 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 99

Last updated 2024-04-29

No results posted yet for this study

Summary

This study is planned to Evaluate the Efficacy and Safety of test drug (AJU-S56) compared to control drug(vehicle) in Patients with Dry Eye Disease.

Conditions

  • Dry Eye Syndromes

Interventions

DRUG

(AJU-S56 5% and placebo)

(AJU-S56 5%) and placebo(Vehicle), 1drop/1times, 3times in a day

DRUG

AJU-S56 5%

(AJU-S56 5%), 1drop/1times, 6times in a day

DRUG

Placebo(Vehicle)

Placebo(Vehicle), 1drop/1times, 6times in a day

Sponsors & Collaborators

  • GL Pharm Tech Corporation

    collaborator INDUSTRY

  • AJU Pharm Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-22
Primary Completion
2022-06-14
Completion
2022-11-28

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06337981 on ClinicalTrials.gov